Company intelligence / Profile preview
Mediforum
Seoul, Seoul, South Koreamediforum.us ↗
- Ownership
- Public · 047920
- Development stage
- Other
01
Overview
Mediforum is a Korean biotechnology company specializing in safe pharmaceuticals derived from natural materials. It has reached Phase 3 clinical trials in Korea for its lead Alzheimer’s drug—reportedly the first to do so—and markets synbiotic products and diagnostic kits. The company emphasizes safety, efficacy, and innovation with a pipeline focused on neurodegenerative diseases and infectious disease diagnostics. Its Qurelac product is a high-potency synbiotic supplement using patented technology.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecules (natural drugs)Synbiotics/probiotics/prebiotics blendsDiagnostic reagents and rapid PCR tests
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
No specific major pharma partnerships named; collaboration with leading university on traditional Korean medicine noted.Investors include Inception Growth Acquisition, Shinhan Investment Corp., eBest Investment & Securities, KOLON INVESTMENT.
Beyond the preview
Go deeper on Mediforum.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mediforum.